K.H. Weiss

552 total citations
21 papers, 396 citations indexed

About

K.H. Weiss is a scholar working on Surgery, Nutrition and Dietetics and Hepatology. According to data from OpenAlex, K.H. Weiss has authored 21 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 6 papers in Nutrition and Dietetics and 5 papers in Hepatology. Recurrent topics in K.H. Weiss's work include Trace Elements in Health (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and IgG4-Related and Inflammatory Diseases (2 papers). K.H. Weiss is often cited by papers focused on Trace Elements in Health (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and IgG4-Related and Inflammatory Diseases (2 papers). K.H. Weiss collaborates with scholars based in Germany, Canada and United States. K.H. Weiss's co-authors include David M. Davidson, Jennifer Peppe, Thomas Louie, David A. Johnson, Gary Garber, Stacey L. Simon, Rezika Mohammed, Joseph F. John, G Dow and Daniel Gotthardt and has published in prestigious journals such as Clinical Infectious Diseases, American Journal of Epidemiology and Journal of Hepatology.

In The Last Decade

K.H. Weiss

20 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.H. Weiss Germany 9 209 177 119 82 45 21 396
Luciano M. Vargas United States 8 144 0.7× 67 0.4× 178 1.5× 43 0.5× 47 1.0× 29 413
Shubham Jain India 10 254 1.2× 52 0.3× 142 1.2× 192 2.3× 37 0.8× 48 471
E. H. H. Wiltink Netherlands 12 202 1.0× 75 0.4× 85 0.7× 28 0.3× 23 0.5× 18 399
Saurabh Saigal India 9 119 0.6× 70 0.4× 81 0.7× 50 0.6× 91 2.0× 40 339
Julnar Mograbi Israel 12 257 1.2× 117 0.7× 114 1.0× 54 0.7× 17 0.4× 15 429
Ronald J. Servi United States 8 295 1.4× 74 0.4× 135 1.1× 138 1.7× 20 0.4× 13 593
G. Ιmvrios Greece 16 204 1.0× 23 0.1× 236 2.0× 201 2.5× 45 1.0× 47 569
Chiara Centenari Italy 6 48 0.2× 78 0.4× 62 0.5× 30 0.4× 20 0.4× 7 218
Edford Sinkala Zambia 13 127 0.6× 80 0.5× 106 0.9× 98 1.2× 35 0.8× 35 352
Patricia K. Mydlow United States 6 131 0.6× 205 1.2× 40 0.3× 51 0.6× 36 0.8× 7 367

Countries citing papers authored by K.H. Weiss

Since Specialization
Citations

This map shows the geographic impact of K.H. Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.H. Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.H. Weiss more than expected).

Fields of papers citing papers by K.H. Weiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.H. Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.H. Weiss. The network helps show where K.H. Weiss may publish in the future.

Co-authorship network of co-authors of K.H. Weiss

This figure shows the co-authorship network connecting the top 25 collaborators of K.H. Weiss. A scholar is included among the top collaborators of K.H. Weiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.H. Weiss. K.H. Weiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Javle, Milind, Robin Kate Kelley, Sameek Roychowdhury, et al.. (2018). Updated results from a phase II study of infigratinib (BGJ398), a selective pan-FGFR kinase inhibitor, in patients with previously treated advanced cholangiocarcinoma containing FGFR2 fusions. Annals of Oncology. 29. viii720–viii720. 33 indexed citations
3.
Weiss, K.H., Fred Askari, Péter Ferenci, et al.. (2018). Long-term efficacy and safety of WTX101 in Wilson disease: Data from an ongoing extension of a phase 2 study (WTX101-201). Journal of Hepatology. 68. S105–S105. 1 indexed citations
4.
Rupp, Christian, Alexander Rössler, Conrad Rauber, et al.. (2017). Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis. United European Gastroenterology Journal. 6(2). 255–262. 19 indexed citations
5.
Weiss, K.H., Fred Askari, Péter Ferenci, et al.. (2017). WTX101 in patients newly diagnosed with Wilson disease: final results of a global, prospective phase 2 trial. Journal of Hepatology. 66(1). S88–S88. 6 indexed citations
6.
Czink, Elena, Christoph Heining, Theresia Weber, et al.. (2016). Dauerhafte Remission unter dualer HER2-Blockade mit Trastuzumab und Pertuzumab bei metastasiertem Gallenblasenkarzinom. Zeitschrift für Gastroenterologie. 54(5). 426–430. 15 indexed citations
7.
Wannhoff, Andreas, Theresa Hippchen, Christian Rupp, et al.. (2016). Cardiac volume overload and pulmonary hypertension in long‐term follow‐up of patients with a transjugular intrahepatic portosystemic shunt. Alimentary Pharmacology & Therapeutics. 43(9). 955–965. 35 indexed citations
8.
Friedrich, Kilian, K.H. Weiss, Wolfgang Stremmel, Peter Schemmer, & Daniel Gotthardt. (2016). CD14 is Associated with Biliary Stricture Formation. Journal of Hepatology. 64(2). S631–S631. 3 indexed citations
9.
Baumann, Cédric, Christoph Antoni, Michael Döllinger, et al.. (2015). Association of serum zinc levels with liver function and survival in patients awaiting liver transplantation. Zeitschrift für Gastroenterologie. 53(8). 1 indexed citations
10.
Wannhoff, Andreas, et al.. (2015). Serum miRNA-122 is an independent biomarker of survival in patients with primary sclerosing cholangitis. Zeitschrift für Gastroenterologie. 53(8). 1 indexed citations
11.
Schmitz, Änne, Nadine Bellemann, Theresa Mokry, et al.. (2014). First experiences with superselective TANDEM® TACE in Heidelberg. Journal of Vascular and Interventional Radiology. 25(3). S150–S151. 1 indexed citations
12.
Wannhoff, Andreas, K.H. Weiss, Peter Schemmer, Wolfgang Stremmel, & Daniel Gotthardt. (2014). Increased Anti-Xa Activity of Rivaroxaban in Patients After Liver Transplantation Treated With Cyclosporine A.. Transplantation. 98. 712–712. 3 indexed citations
13.
Hofer, Heribert, K.H. Weiss, R. H. J. Houwen, et al.. (2013). 1391 PHENOTYPE–GENOTYPE CORRELATIONS IN SIBLINGS OF INDEX PATIENTS WITH WILSON DISEASE. Journal of Hepatology. 58. S559–S559. 1 indexed citations
14.
Weiss, K.H., et al.. (2011). Impact of a Multipronged Education Strategy on Antibiotic Prescribing in Quebec, Canada. Clinical Infectious Diseases. 53(5). 433–439. 41 indexed citations
15.
Weiss, K.H., Daniel Gotthardt, A Maieron, et al.. (2011). 1 EFFICACY AND SAFETY OF D-PENICILLAMINE AND TRIENTINE FOR THE TREATMENT OF WILSON DISEASE. Journal of Hepatology. 54. S1–S1. 3 indexed citations
16.
Weiss, K.H., Daniel Gotthardt, Jan Schmidt, et al.. (2007). Liver transplantation for metabolic liver diseases in adults: indications and outcome. Nephrology Dialysis Transplantation. 22(Supplement 8). viii9–viii12. 11 indexed citations
17.
Riediger, Carina, Pascal O. Berberat, Peter Sauer, et al.. (2007). Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation. Nephrology Dialysis Transplantation. 22(Supplement 8). viii37–viii46. 19 indexed citations
18.
Louie, Thomas, Jennifer Peppe, David A. Johnson, et al.. (2006). Tolevamer, a Novel Nonantibiotic Polymer, Compared with Vancomycin in the Treatment of Mild to Moderately Severe Clostridium difficile-Associated Diarrhea. Clinical Infectious Diseases. 43(4). 411–420. 154 indexed citations
19.
Weiss, K.H., et al.. (1999). Group A Streptococcus Carriage among Close Contacts of Patients with Invasive Infections. American Journal of Epidemiology. 149(9). 863–868. 36 indexed citations
20.
Adam, W. R., et al.. (1963). INTESTINAL EXCRETION OF URIC ACID IN DOGS.. PubMed. 4. 201–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luciano M. Vargas Breakdown of academic impact, for papers by Shubham Jain Breakdown of academic impact, for papers by E. H. H. Wiltink Breakdown of academic impact, for papers by Saurabh Saigal Breakdown of academic impact, for papers by Julnar Mograbi Breakdown of academic impact, for papers by Ronald J. Servi Breakdown of academic impact, for papers by G. Ιmvrios Breakdown of academic impact, for papers by Chiara Centenari Breakdown of academic impact, for papers by Edford Sinkala Breakdown of academic impact, for papers by Patricia K. Mydlow
Rankless by CCL
2026